SCHEMBL23961642

SCHEMBL23961642

CCCNc1nc(N(C)c2ccccc2)c2ncn(C(C)C)c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.55
▸ NPSR1 Q6W5P4 2/20 0.55
▸ MAPT P10636 2/20 0.55
▸ MAPK1 P28482 2/20 0.55
▸ MDM2 Q00987 1/20 0.55
▸ KDM4E B2RXH2 1/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ CDK2 P24941 13/20 0.51
▸ CDK1 P06493 11/20 0.51
▸ CDK5 Q00535 4/20 0.51
▸ CSNK1D P48730 1/20 0.51
▸ CLK2 P49760 1/20 0.51
▸ DYRK1A Q13627 1/20 0.51
▸ HIPK4 Q8NE63 1/20 0.51
▸ SRPK1 Q96SB4 1/20 0.51
▸ CLK4 Q9HAZ1 1/20 0.51
▸ CCNB1 P14635 5/20 0.49
▸ CCNB2 O95067 2/20 0.49
▸ CCNB3 Q8WWL7 2/20 0.49
▸ CCNE1 P24864 8/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112102 0.90 CDK1 (0.63) TDP1NPSR1MAPTMAPK1MDM2
SCHEMBL23927311 0.83 NPSR1 (0.54) TDP1NPSR1MAPTMAPK1MDM2
SCHEMBL22651961 0.82 NPSR1 (0.70) TDP1NPSR1MAPTMAPK1MDM2
SCHEMBL15387124 0.81 NPSR1 (0.67) NPSR1MAPK1CDK2CDK1CDK5
SCHEMBL19112192 0.81 NPSR1 (0.67) NPSR1MAPK1CDK2CDK1CDK5
SCHEMBL19112178 0.81 NPSR1 (0.67) NPSR1MAPK1CDK2CDK1CDK5
SCHEMBL30356263 0.81 NPSR1 (0.67) NPSR1MAPK1CDK2CDK1CDK5
Hydrochloric Acid SCHEMBL23927317 0.81 NPSR1 (0.66) NPSR1MAPK1CDK2CDK1CDK5
SCHEMBL17004029 0.81 CDK2 (0.65) TDP1NPSR1MAPTMAPK1MDM2
Hydrochloric Acid SCHEMBL23927315 0.81 NPSR1 (0.66) NPSR1MAPK1CDK2CDK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214315-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2021-10-28 — — WO disclosed
Send feedback